Human induced pluripotent stem cell-derived extracellular vesicles reduce hepatic stellate cell activation and liver fibrosis

被引:87
作者
Povero, Davide [1 ]
Pinatel, Eva M. [2 ]
Leszczynska, Aleksandra [1 ]
Loyal, Nidhi P. [1 ]
Nishio, Takahiro [3 ]
Kim, Jihoon [4 ]
Kneiber, David [1 ]
Horcel, Lucas de Araujo [1 ,5 ]
Eguchi, Akiko [1 ]
Ordonez, Paulina M. [1 ]
Kisseleva, Tatiana [3 ]
Feldstein, Ariel E. [1 ]
机构
[1] UCSD, Dept Pediat, La Jolla, CA 92103 USA
[2] CNR, Inst Biomed Technol, Segrate, Italy
[3] UCSD, Dept Surg, Sch Med, La Jolla, CA 92103 USA
[4] UCSD, Dept Biomed Informat, Sch Med, La Jolla, CA 92103 USA
[5] Univ Ctr Lusiada, Santos, Brazil
关键词
EXOSOMES; MICROVESICLES; PATHOGENESIS; MECHANISMS; PROTEOMICS; RESPONSES; REPAIR;
D O I
10.1172/jci.insight.125652
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Progression of fibrosis and the development of cirrhosis are responsible for the liver-related morbidity and mortality associated with chronic liver diseases. There is currently a great unmet need for effective antifibrotic strategies. Stem cells play a central role in wound-healing responses to restore liver homeostasis following injury. Here we tested the hypothesis that extracellular vesicles (EVs) isolated from induced pluripotent stem cells (iPSCs) modulate hepatic stellate cell (HSC) activation and may have antifibrotic effects. Human iPSCs were generated by reprogramming primary skin fibroblasts. EVs were isolated by differential centrifugation, quantified by flow cytometry (FACS), and characterized by dynamic light scattering and transmission electron microscopy (TEM). Primary human HSCs were activated with TGF-beta (10 ng/mL) and exposed to iPSC-EVs. Efficacy of iPSC-EVs was tested on HSCs in vitro and in 2 murine models of liver injury (CCl4 and bile duct ligation). Characterization of iPSC-derived EVs by flow cytometry identified a large population of EVs released by iPSCs, primarily with a diameter of 300 nm, that could be visualized by TEM as round, cup-shaped objects. Fluorescent tracing assays detected iPSC-EVs in HSC cytosol after a short incubation, and EV uptake by HSCs resulted in both decrease of profibrogenic markers alpha-smooth muscle actin, CollagenIa1, fibronectin, and tissue inhibitor of metalloproteinases-1 and HSC profibrogenic responses, such as chemotaxis and proliferation. Genomics analyses of iPSC-EV miRNA cargo revealed 22 highly expressed miRNAs, among which miR-92a-3p was the most abundant. Transcriptome analysis identified 60 genes downmodulated and 235 upregulated in TGF-beta-primed HSCs in the presence or absence of iPSC-EVs. Intravenous injection of iPSC-EVs in CCl4-induced and bile duct ligation-induced liver fibrosis resulted in antifibrotic effects at protein and gene levels. Results of this study identify iPSC-EVs as a potentially novel antifibrotic approach that may reduce or reverse liver fibrosis in patients with chronic liver disease.
引用
收藏
页数:17
相关论文
共 45 条
[31]  
LOVE MI, 2014, GENOME BIOL, V15, DOI [DOI 10.1186/S13059-014-0550-8, 10.1186/s13059-014-0550-8]
[32]   Predicting the future burden of NAFLD and NASH [J].
Mahady, Suzanne E. ;
George, Jacob .
JOURNAL OF HEPATOLOGY, 2018, 69 (04) :774-775
[33]   Lipid-Induced Hepatocyte-Derived Extracellular Vesicles Regulate Hepatic Stellate Cells via MicroRNA Targeting Peroxisome Proliferator-Activated Receptor-gamma [J].
Povero, Davide ;
Panera, Nadia ;
Eguchi, Akiko ;
Johnson, Casey D. ;
Papouchado, Bettina G. ;
Horcel, Lucas de Araujo ;
Pinatel, Eva M. ;
Alisi, Anna ;
Nobili, Valerio ;
Feldstein, Ariel E. .
CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY, 2015, 1 (06) :646-+
[34]   Circulating Extracellular Vesicles with Specific Proteome and Liver MicroRNAs Are Potential Biomarkers for Liver Injury in Experimental Fatty Liver Disease [J].
Povero, Davide ;
Eguchi, Akiko ;
Li, Hongying ;
Johnson, Casey D. ;
Papouchado, Bettina G. ;
Wree, Alexander ;
Messer, Karen ;
Feldstein, Ariel E. .
PLOS ONE, 2014, 9 (12)
[35]   Lipid-Induced Toxicity Stimulates Hepatocytes to Release Angiogenic Microparticles That Require Vanin-1 for Uptake by Endothelial Cells [J].
Povero, Davide ;
Eguchi, Akiko ;
Niesman, Ingrid R. ;
Andronikou, Nektaria ;
du Jeu, Xavier de Mollerat ;
Mulya, Anny ;
Berk, Michael ;
Lazic, Milos ;
Thapaliya, Samjana ;
Parola, Maurizio ;
Patel, Hemal H. ;
Feldstein, Ariel E. .
SCIENCE SIGNALING, 2013, 6 (296)
[36]   Role of extracellular RNA-carrying vesicles in cell differentiation and reprogramming [J].
Quesenberry, Peter J. ;
Aliotta, Jason ;
Deregibus, Maria Chiara ;
Camussi, Giovanni .
STEM CELL RESEARCH & THERAPY, 2015, 6
[37]   Mesenchymal Stem Cell-derived Extracellular Vesicles: Toward Cell-free Therapeutic Applications [J].
Rani, Sweta ;
Ryan, Aideen E. ;
Griffin, Matthew D. ;
Ritter, Thomas .
MOLECULAR THERAPY, 2015, 23 (05) :812-823
[38]   Extracellular vesicles: Exosomes, microvesicles, and friends [J].
Raposo, Graca ;
Stoorvogel, Willem .
JOURNAL OF CELL BIOLOGY, 2013, 200 (04) :373-383
[39]   Stem Cell Extracellular Vesicles: Extended Messages of Regeneration [J].
Riazifar, Milad ;
Pone, Egest J. ;
Lotvall, Jan ;
Zhao, Weian .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 57, 2017, 57 :125-154
[40]   Regulation of immune responses by extracellular vesicles [J].
Robbins, Paul D. ;
Morelli, Adrian E. .
NATURE REVIEWS IMMUNOLOGY, 2014, 14 (03) :195-208